BRIEF-Atos Says It Will Appeal Amended Final Judgment In TriZetto Litigation

Atossa Therapeutics, Inc.
Cognizant Technology Solutions Corporation Class A

Atossa Therapeutics, Inc.

ATOS

0.00

Cognizant Technology Solutions Corporation Class A

CTSH

0.00

May 20 (Reuters) - Atos SE ATOS.PA:

  • ANNOUNCES APPEAL OF THE AMENDED FINAL JUDGMENT IN THE TRIZETTO LITIGATION

  • UNITED STATES DISTRICT COURT FOR SOUTHERN DISTRICT OF NEW YORK ORDERED ATOS AND ITS SUBSIDIARY SYNTEL TO PAY US$297.9 MILLION

  • HAS IMPLEMENTED A SUPERSEDEAS BOND IN AN AMOUNT EQUAL TO FULL JUDGMENT

  • DECISION DOES NOT HAVE A MATERIAL ADVERSE IMPACT ON ITS ASSETS, BUSINESS, LIQUIDITY OR FINANCIAL CONDITION

Source text: nGNE6ZlQVr

Further company coverage: ATOS.PA


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.